
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc has demonstrated a positive trajectory in its operations, achieving a 3% year-over-year increase in same-store admissions due to effective referral source action plans, indicating its ability to enhance patient inflow despite softer patient days. The company anticipates a significant rise in its net PLGL liability by the end of 2025, reflecting proactive financial management and a strategic outlook on handling claims, while also planning a substantial reduction in capital expenditures by $300 million year-over-year in 2026, which is expected to bolster cash flow. Furthermore, Acadia's robust capacity for mergers and acquisitions, coupled with strong demand in the behavioral health sector and impressive organic growth through facility expansions and new developments, positions the company favorably for continued market success.
Bears say
Acadia Healthcare Co Inc has faced continuous downward revisions to its guidance due to underestimating PLGL expenses and experiencing ongoing volume softness, leading to significant reductions in adjusted EBITDA expectations for both 2025 and 2026. The projected EBITDA for 2025 has declined by $32.5 million, while the estimate for 2026 was lowered to $664.6 million, reflecting persistent reimbursement headwinds and operational challenges. Overall prospects remain gloomy as the company's shift towards lower capital expenditures and limited growth in bed availability may hinder its ability to achieve sustainable revenue recovery.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares